Technetium Tc 99m Exametazime
"Technetium Tc 99m Exametazime" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A gamma-emitting RADIONUCLIDE IMAGING agent used in the evaluation of regional cerebral blood flow and in non-invasive dynamic biodistribution studies and MYOCARDIAL PERFUSION IMAGING. It has also been used to label leukocytes in the investigation of INFLAMMATORY BOWEL DISEASES.
| Descriptor ID |
D019690
|
| MeSH Number(s) |
D02.092.570.665.810 D02.691.825.562
|
| Concept/Terms |
Technetium Tc 99m Exametazime- Technetium Tc 99m Exametazime
- Tc-99m-Exametazime
- Tc 99m Exametazime
- 99m-Tc-HMPAO
- 99mTc-HMPAO
- Technetium Tc 99m Hexamethylpropylene-amine Oxime
- Technetium Tc 99m Hexamethylpropylene amine Oxime
- Tc-99m-Hexamethylpropyleneamine Oxime
- Tc 99m Hexamethylpropyleneamine Oxime
- Technetium Tc 99m Hexamethylpropyleneamine Oxime
- Tc-99m HMPAO
|
Below are MeSH descriptors whose meaning is more general than "Technetium Tc 99m Exametazime".
Below are MeSH descriptors whose meaning is more specific than "Technetium Tc 99m Exametazime".
This graph shows the total number of publications written about "Technetium Tc 99m Exametazime" by people in this website by year, and whether "Technetium Tc 99m Exametazime" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2004 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Technetium Tc 99m Exametazime" by people in Profiles.
-
Changes in regional cerebral blood flow and three-phase bone scan after repeated somatic nerve blocks for sympathetically independent pain. Clin Nucl Med. 2010 Jun; 35(6):391-5.
-
Gender-specific vulnerability for rCBF abnormalities among cocaine abusers. Neuroreport. 2004 Apr 09; 15(5):797-801.
-
Cerebral blood flow changes in depressed patients after treatment with repetitive transcranial magnetic stimulation: evidence of individual variability. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Sep; 15(3):159-75.
-
Cerebral perfusion defects in combined cocaine and alcohol dependence. Drug Alcohol Depend. 2002 Sep 01; 68(1):95-104.
-
Attenuation compensation in 99mTc SPECT brain imaging: a comparison of the use of attenuation maps derived from transmission versus emission data in normal scans. J Nucl Med. 1999 Mar; 40(3):456-63.
-
Epilepsy surgery in the first three years of life. Epilepsia. 1998 Jul; 39(7):737-43.
-
Central nervous system perfusion and metabolism abnormalities in Sturge-Weber syndrome. J Child Neurol. 1997 Apr; 12(3):218-22.
-
Correlations between SPECT regional cerebral blood flow and psychometric testing in patients with Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1997; 9(1):68-74.
-
Acute cocaine effects on absolute cerebral blood flow. Psychopharmacology (Berl). 1996 Nov; 128(1):17-20.
-
SPECT findings on psychosis in Alzheimer's disease. Am J Psychiatry. 1995 Oct; 152(10):1470-5.